Skip to main content

Table 1 Clinicopathological characteristics of breast cancers according to CEA or CA15–3 levels

From: Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes

Characteristics

CEA higha (n = 191)

CEA lowa (n = 885)

p value

CA15-3 highb (n = 314)

CA15-3 lowb (n = 762)

p value

Menopausal status

 Pre-

30 (8.3)c

330 (91.7)

< 0.0001

96 (26.7)

264 (73.3)

0.200

 Post-

157 (22.3)

546 (77.7)

 

214 (30.4)

489 (69.6)

 

 Unknown

4 (30.8)

9 (69.2)

 

4 (30.8)

9 (69.2)

 

Histological type

 IDC

165 (16.9)

806 (83.1)

0.096

278 (28.6)

693 (71.4)

0.276

 ILC

8 (20.5)

31 (79.5)

 

11 (28.2)

28 (71.8)

 

 Others

18 (27.3)

48 (72.7)

 

25 (37.9)

41 (62.1)

 

Tumor size

 ≤ 2 cm

87 (13.6)

552 (86.4)

< 0.0001

157 (24.6)

482 (75.4)

< 0.0001

 > 2 cm

102 (23.9)

324 (76.1)

 

155 (36.4)

271 (63.6)

 

 Unknown

2 (18.2)

9 (81.8)

 

2 (18.2)

9 (81.8)

 

Lymph node metastasis

 Negative

121 (16.3)

622 (83.7)

0.036

186 (25.0)

557 (75.0)

< 0.0001

 Positive

64 (20.2)

253 (79.8)

 

123 (38.8)

194 (61.2)

 

 Not examined

6 (37.5)

10 (62.5)

 

5 (31.3)

11 (68.8)

 

Tumor grade

 1

90 (16.0)

471 (84.0)

0.251

156 (27.8)

405 (72.2)

0.424

 2 + 3

90 (18.8)

389 (81.2)

 

144 (30.1)

335 (69.9

 

 Unknown

11 (30.6)

25 (69.4)

 

14 (38.9)

22 (61.1)

 

Estrogen receptor

 Positive

144 (16.9)

709 (83.1)

0.168

235 (27.6)

618 (72.5)

0.021

 Negative

47 (21.1)

176 (78.9)

 

79 (35.4)

144 (64.6)

 

Progesterone receptor

 Positive

113 (15.4)

622 (84.6)

0.0025

197 (26.8)

538 (73.2)

0.013

 Negative

78 (23.2)

258 (76.8)

 

115 (34.2)

221 (65.8)

 

 Unknown

0 (0.0)

5 (100.0)

 

2 (40.0)

3 (60.0)

 

HER2 status

 Negative

150 (16.7)

747 (83.3)

0.044

248 (27.6)

649 (72.4)

0.024

 Positive

38 (23.5)

124 (76.5)

 

59 (36.4)

103 (63.6)

 

 Unknown

3 (17.6)

14 (82.4)

 

7 (41.2)

10 (58.8)

 

Ki67 statusd

 Low

65 (20.2)

256 (79.8)

0.764

99 (30.8)

222 (69.2)

0.098

 High

60 (21.3)

222 (78.7)

 

105 (37.2)

177 (62.8)

 

 Unknown

66 (14.0)

407 (86.0)

 

110 (23.3)

365 (76.7)

 

Chemotherapy

 Yes

89 (17.4)

423 (82.6)

0.870

171 (33.4)

341 (66.6)

0.0011

 No

92 (18.0)

420 (82.0)

 

123 (24.0)

389 (76.0)

 

 Unknown

10 (19.2)

42 (80.8)

 

20 (38.5)

32 (61.5)

 
  1. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma
  2. aHigh: ≥ 3.2ng/mL, low: < 3.2ng/mL
  3. bHigh ≥ 13.3 U/mL, low < 13.3 U/mL
  4. c(%)
  5. dLow < 20%, high ≥ 20%